journal article·2019-06

Tracking stem cells and macrophages with gold and iron oxide nanoparticles – The choice of the best suited particles

Xing Sun, Mahmoud Gamal, Philipp Nold, Alaa Said, Indranath Chakraborty, Beatriz Pelaz, Franziska Schmied, Kerstin von Pückler, Jens Figiel, Ying Zhao, Cornelia Brendel, Moustapha Hassan, Wolfgang J. Parak, Neus Feliu

Publisher page

Abstract

Abstract Nanoparticle (NP)-based cell imaging offers good potential for future diagnosis tools in medicine. Gold and iron oxide NPs can be used as contrast agents for imaging by computed tomography (CT) and magnetic resonance imaging (MRI), respectively. Thus, also cells which have been labeled with these NPs may be tracked. This may be important for in vivo tracking of administered or transplanted cells. In this work, we optimized the conditions to label stem cells and macrophages with a library of gold and iron oxide NPs of different sizes (5–100 nm core diameter) and shapes. We investigated the amount of NPs which can be delivered to different cells, as well as their related toxic effects, in relation to the physicochemical properties of the NPs. Our study revealed that in general, when cells are exposed to NPs at similar elemental concentration (e.g., Au or Fe), bigger NPs lead to higher internalized elemental amounts as compared to exposure with smaller sized NPs. While the exposure concentrations are limited concerning the onset of toxicity, bigger NPs lead to better labeling than small NPs, resulting in improved contrast for imaging with enhanced biocompatibility.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Analysis of nanoparticle delivery to tumours10.1038/natrevmats.2016.14 ↗
2. Systemically infused mesenchymal stem cells show different homing profiles in healthy and tumor mouse models10.1002/sctm.16-0204 ↗
3. Mesenchymal stem cells (MSC) derived from induced pluripotent stem cells (iPSC) equivalent to adipose-derived MSC in promoting intestinal healing and microbiome normalization in mouse inflammatory bowel disease model10.1002/sctm.17-0305 ↗
4. Tumour-associated macrophages as treatment targets in oncology10.1038/nrclinonc.2016.217 ↗
5. Exploiting homing abilities of cell carriers: targeted delivery of nanoparticles for cancer therapy10.1016/j.bcp.2017.09.006 ↗
6. Targeted delivery of doxorubicin by nano-loaded mesenchymal stem cells for lung melanoma metastases therapy10.1038/srep44758 ↗
7. Behaviour of adipose-derived canine mesenchymal stem cells after superparamagnetic iron oxide nanoparticles labelling for magnetic resonance imaging
8. Macrophages homing to metastatic lymph nodes can be monitored with ultrasensitive ferromagnetic iron-oxide nanocubes and a 1.5T clinical MR scanner10.1371/journal.pone.0029575 ↗
9. In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis10.1073/pnas.1609397113 ↗
10. Tracking immune cells in vivo using magnetic resonance imaging10.1038/nri3531 ↗
11. A unique (19)F MRI agent for the tracking of non phagocytic cells in vivo10.1039/C8NR00703A ↗
12. A new method for preparing mesenchymal stem cells and labeling with ferumoxytol for cell tracking by MRI10.1038/srep26271 ↗
13. In vivo fate of free and encapsulated iron oxide nanoparticles after injection of labelled stem cells10.1039/C8NA00098K ↗
14. Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications10.1021/ar300150c ↗
15. Preventing plasmon coupling between gold nanorods improves the sensitivity of photoacoustic detection of labeled stem cells in vivo10.1021/acsnano.6b03246 ↗
16. Photoacoustic imaging of human mesenchymal stem cells labeled with prussian blue-poly(l-lysine) nanocomplexes10.1021/acsnano.7b03519 ↗
17. Quantum dots: bright and versatile in vitro and in vivo fluorescence imaging biosensors10.1039/C4CS00532E ↗
18. In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution
19. Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs10.1186/s12951-017-0258-5 ↗
20. Use of macrophages to deliver therapeutic and imaging contrast agents to tumors10.1016/j.biomaterials.2012.02.022 ↗
21. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas10.1158/0008-5472.CAN-08-4242 ↗
22. Human induced pluripotent stem cells for tumor targeted delivery of gold nanorods and enhanced photothermal therapy10.1021/acsnano.5b07172 ↗
23. Nanoparticles in photodynamic therapy10.1021/cr5004198 ↗
24. Clinical imaging in regenerative medicine10.1038/nbt.2993 ↗
25. Nanomaterials in neural-stem-cell-mediated regenerative medicine: imaging and treatment of neurological diseases10.1002/adma.201705694 ↗
26. Multifunctional nanoparticles as coupled contrast agents
27. Multimodal gadolinium oxysulfide nanoparticles: a versatile contrast agent for mesenchymal stem cell labeling10.1039/C8NR03263G ↗
28. Diverse applications of nanomedicine10.1021/acsnano.6b06040 ↗
29. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells10.1021/nl052396o ↗
30. Quantitative uptake of colloidal particles by cell cultures10.1016/j.scitotenv.2016.05.213 ↗
31. P. Sprawls, X-ray image formation and contrast, http://www.sprawls.org/resources.
32. X-ray-computed tomography contrast agents10.1021/cr200358s ↗
33. Nanoparticle dosage-a nontrivial task of utmost importance for quantitative nanosafety research10.1002/wnan.1378 ↗
34. Towards the prediction of protein corona formation and in vitro and in vivo interactions of gold nanoparticles based on their physicochemical properties10.1021/acsnano.8b04906 ↗
35. Selected standard protocols for the synthesis phase transfer, and characterization of inorganic colloidal nanoparticles10.1021/acs.chemmater.6b04738 ↗
36. Quantitative particle–cell interaction: some basic physicochemical pitfalls10.1021/acs.langmuir.6b04629 ↗
37. Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials10.1038/nprot.2016.172 ↗
38. Nanoparticle uptake: the phagocyte problem10.1016/j.nantod.2015.06.006 ↗
39. Cell motility and metastatic potential studies based on quantum dot imaging of phagokinetic tracks10.1002/1521-4095(20020618)14:12<882::AID-ADMA882>3.0.CO;2-Y ↗
40. The interface of nanoparticles with proliferating mammalian cells10.1038/nnano.2017.140 ↗
41. Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles10.1038/nprot.2006.11 ↗
42. Exocytosis of peptide functionalized gold nanoparticles in endothelial cells10.1039/c2nr31064c ↗
43. Endocytosis and exocytosis of nanoparticles in mammalian cells
44. Surface chemistry of gold nanoparticles mediates their exocytosis in macrophages10.1021/nn501668a ↗
45. Next-generation sequencing reveals low-dose effects of cationic dendrimers in primary human bronchial epithelial cells10.1021/nn5061783 ↗
46. Controlling the cellular uptake of gold nanorods10.1021/la062642r ↗
47. Phase transfer and polymer coating methods toward improving the stability of metallic nanoparticles for biological applications10.1021/cm5043167 ↗
48. Colloidal gold nanoparticles induce changes in cellular and subcellular morphology10.1021/acsnano.7b01760 ↗
49. Neglected nano-effects of nanoparticles in the interpretation of their toxicity10.1039/C7AN01707C ↗
50. Good manufacturing practice-compliant animal-free expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor10.1016/j.bbrc.2012.11.001 ↗
51. Zwitterionic surface coating of quantum dots reduces protein adsorption and cellular uptake